Hence, the present findings show, for the first time, that microglia-derived preconditioned EVs protect against stroke-induced brain injury by diminishing postischemic inflammation, astrogliosis, CSF flow impairment, and AQP4 depolarization, indicating that this investigation may represent a novel perspective for stroke treatment. Here, AQP4 is linked to stroke disorder.